| Autor: |
Girouard, Joel, Forest, Jean-Claude, Masse, Jacques, Leroux, Michael, Bradburn, Niceta C., Noblet, Thomas C., Joynes, Judy Ostrom, Baum, John, Girouard, J, Forest, J C, Massé, J, Leroux, M, Bradburn, N C, Noblet, T C, Joynes, J O, Baum, J |
| Předmět: |
|
| Zdroj: |
Diabetes Care; Aug2000, Vol. 23 Issue 8, p1149-1153, 5p, 4 Graphs |
| Abstrakt: |
Objective: To evaluate the clinical performance of the Glucometer Elite XL Diabetes Care System in neonatal settings using a multicenter studyResearch Design and Methods: A total of 388 blood specimens from 333 neonates were included in the study. A capillary or arterial sample was analyzed for determination of glucose with the Glucometer Elite XL system by an attending trained nurse. Through the same sampling site, a specimen was collected and sent to the laboratory for measurement of plasma glucose, bilirubin, and hematocrit.Results: The regression analysis between the results of the Glucometer Elite XL system and comparative methods resulted in the following: Glucometer Elite XL meter = 1.01 x laboratory method + 0.02 mmol/l (n = 388). For the 1.1-4.0 mmol/l plasma glucose range, the regression was Glucometer Elite XL meter = 1.07 x laboratory method + 0.12 mmol/l (n = 150). A difference plot indicated a mean bias of 0.04 mmol/l (95% CI -0.01 to 0.10). No relationship was found between meter glucose biases and hematocrit levels (r = 0.10, P = 0.14). Although a statistically significant correlation existed between bilirubin levels and the glucose meter biases (r = 0.14, P = 0.005), the predicted mean biases were of little clinical significance.Conclusions: The Glucometer Elite XL system showed a good performance when used in neonatal settings. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
